| Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Bone Marrow Cells | 30 | 2019 | 2409 | 3.630 |
Why?
|
| Osteoblasts | 23 | 2021 | 1141 | 2.930 |
Why?
|
| Mesenchymal Stem Cells | 18 | 2021 | 1642 | 2.680 |
Why?
|
| Chondrocytes | 17 | 2015 | 792 | 2.280 |
Why?
|
| Calcifediol | 7 | 2019 | 161 | 2.080 |
Why?
|
| Bone Transplantation | 31 | 2015 | 927 | 1.910 |
Why?
|
| Osteogenesis | 34 | 2020 | 1270 | 1.760 |
Why?
|
| Osteoclasts | 24 | 2014 | 711 | 1.750 |
Why?
|
| Vitamin D | 16 | 2021 | 3302 | 1.570 |
Why?
|
| Stromal Cells | 14 | 2019 | 1329 | 1.500 |
Why?
|
| Cell Differentiation | 38 | 2021 | 11514 | 1.300 |
Why?
|
| Collagen | 29 | 2010 | 2634 | 1.300 |
Why?
|
| Bone and Bones | 28 | 2014 | 2565 | 1.180 |
Why?
|
| Parathyroid Hormone | 8 | 2015 | 1803 | 1.130 |
Why?
|
| Chondrogenesis | 8 | 2012 | 238 | 1.110 |
Why?
|
| Cartilage | 13 | 2005 | 806 | 1.080 |
Why?
|
| 25-Hydroxyvitamin D3 1-alpha-Hydroxylase | 5 | 2020 | 58 | 1.010 |
Why?
|
| Bone Demineralization Technique | 10 | 2015 | 27 | 0.990 |
Why?
|
| Osteoporosis | 8 | 2018 | 1604 | 0.980 |
Why?
|
| Mandible | 12 | 2007 | 753 | 0.910 |
Why?
|
| Osteoarthritis, Hip | 4 | 2011 | 409 | 0.900 |
Why?
|
| Dehydroepiandrosterone | 5 | 2018 | 258 | 0.900 |
Why?
|
| Osteogenesis, Distraction | 9 | 2010 | 227 | 0.890 |
Why?
|
| Tissue Engineering | 8 | 2009 | 1865 | 0.880 |
Why?
|
| Bone Resorption | 20 | 2017 | 723 | 0.870 |
Why?
|
| Bone Matrix | 7 | 2009 | 120 | 0.800 |
Why?
|
| Transforming Growth Factor beta | 8 | 2009 | 1963 | 0.790 |
Why?
|
| Fibroblasts | 15 | 2012 | 4137 | 0.790 |
Why?
|
| Biocompatible Materials | 11 | 2005 | 1683 | 0.750 |
Why?
|
| Bone Density | 15 | 2018 | 3548 | 0.740 |
Why?
|
| Surgery, Oral | 1 | 2022 | 130 | 0.710 |
Why?
|
| Rodentia | 1 | 2021 | 261 | 0.690 |
Why?
|
| Aging | 17 | 2014 | 8699 | 0.690 |
Why?
|
| Cells, Cultured | 37 | 2021 | 18937 | 0.650 |
Why?
|
| Bone Morphogenetic Protein 2 | 2 | 2012 | 343 | 0.640 |
Why?
|
| Cartilage, Articular | 5 | 2015 | 1099 | 0.630 |
Why?
|
| Bone Morphogenetic Proteins | 5 | 2015 | 841 | 0.630 |
Why?
|
| Alendronate | 2 | 2011 | 175 | 0.620 |
Why?
|
| Tissue Scaffolds | 3 | 2009 | 932 | 0.600 |
Why?
|
| Fracture Healing | 4 | 2015 | 445 | 0.570 |
Why?
|
| Bone Regeneration | 5 | 2009 | 432 | 0.560 |
Why?
|
| Extracellular Matrix Proteins | 7 | 2009 | 829 | 0.560 |
Why?
|
| Absorptiometry, Photon | 5 | 2011 | 1738 | 0.550 |
Why?
|
| Receptor, Parathyroid Hormone, Type 1 | 2 | 2015 | 305 | 0.530 |
Why?
|
| Tibia | 5 | 2014 | 1069 | 0.520 |
Why?
|
| Osteoporosis, Postmenopausal | 6 | 2011 | 396 | 0.520 |
Why?
|
| Tissue Preservation | 3 | 2015 | 174 | 0.520 |
Why?
|
| Insulin-Like Growth Factor I | 8 | 2018 | 1932 | 0.510 |
Why?
|
| Radiation Injuries | 2 | 2021 | 1189 | 0.510 |
Why?
|
| Leptin | 3 | 2021 | 1595 | 0.500 |
Why?
|
| Wound Healing | 13 | 2021 | 2802 | 0.490 |
Why?
|
| Vitamin D Deficiency | 5 | 2008 | 1388 | 0.490 |
Why?
|
| Estradiol | 3 | 2017 | 1937 | 0.480 |
Why?
|
| Receptors, Calcitriol | 5 | 2020 | 360 | 0.480 |
Why?
|
| Bone Substitutes | 4 | 2001 | 236 | 0.480 |
Why?
|
| Gene Expression Regulation | 8 | 2017 | 11874 | 0.480 |
Why?
|
| Osteocalcin | 10 | 1999 | 274 | 0.440 |
Why?
|
| Osteoarthritis | 2 | 2015 | 1063 | 0.440 |
Why?
|
| Cattle | 13 | 2012 | 3841 | 0.440 |
Why?
|
| Jaw Abnormalities | 2 | 2013 | 27 | 0.440 |
Why?
|
| Renal Insufficiency, Chronic | 3 | 2020 | 2249 | 0.430 |
Why?
|
| RANK Ligand | 2 | 2014 | 318 | 0.430 |
Why?
|
| Adipocytes | 5 | 2011 | 1187 | 0.420 |
Why?
|
| Maxillofacial Development | 1 | 2013 | 87 | 0.420 |
Why?
|
| Jaw | 1 | 2013 | 93 | 0.420 |
Why?
|
| Osseointegration | 4 | 2011 | 274 | 0.420 |
Why?
|
| Cyclic AMP Response Element-Binding Protein | 2 | 2011 | 502 | 0.390 |
Why?
|
| Hip Fractures | 4 | 2011 | 988 | 0.390 |
Why?
|
| Cell Culture Techniques | 10 | 2005 | 1662 | 0.380 |
Why?
|
| Bone Density Conservation Agents | 2 | 2009 | 794 | 0.370 |
Why?
|
| Transforming Growth Factor beta1 | 2 | 2012 | 630 | 0.360 |
Why?
|
| Collagen Type II | 3 | 2006 | 148 | 0.360 |
Why?
|
| Femur Neck | 2 | 2010 | 314 | 0.360 |
Why?
|
| Ilium | 2 | 2010 | 154 | 0.360 |
Why?
|
| Sex Characteristics | 2 | 2013 | 2637 | 0.360 |
Why?
|
| Chondroitin Sulfate Proteoglycans | 3 | 2006 | 141 | 0.350 |
Why?
|
| Wnt Proteins | 3 | 2011 | 718 | 0.350 |
Why?
|
| Gene Expression | 12 | 2019 | 7568 | 0.350 |
Why?
|
| Estrogens | 4 | 2001 | 1521 | 0.350 |
Why?
|
| Lectins, C-Type | 4 | 2006 | 584 | 0.340 |
Why?
|
| Signal Transduction | 11 | 2012 | 23416 | 0.340 |
Why?
|
| Alveolar Bone Loss | 1 | 2013 | 390 | 0.340 |
Why?
|
| Radiation Tolerance | 1 | 2012 | 478 | 0.330 |
Why?
|
| Fractures, Spontaneous | 2 | 2008 | 231 | 0.330 |
Why?
|
| Gene Expression Regulation, Developmental | 4 | 2020 | 3608 | 0.320 |
Why?
|
| Prostheses and Implants | 7 | 2010 | 1269 | 0.320 |
Why?
|
| Animals | 89 | 2021 | 168201 | 0.320 |
Why?
|
| Biomedical Engineering | 2 | 2001 | 286 | 0.320 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 9 | 2012 | 4570 | 0.310 |
Why?
|
| Powders | 10 | 2005 | 80 | 0.310 |
Why?
|
| Postmenopause | 8 | 2007 | 2511 | 0.310 |
Why?
|
| Culture Media | 5 | 2019 | 895 | 0.300 |
Why?
|
| RNA, Small Interfering | 6 | 2019 | 3419 | 0.300 |
Why?
|
| Oral Surgical Procedures | 2 | 2007 | 166 | 0.280 |
Why?
|
| Extracellular Matrix | 5 | 2005 | 1718 | 0.280 |
Why?
|
| Steroid Hydroxylases | 3 | 2011 | 93 | 0.270 |
Why?
|
| Interleukin-1 | 4 | 2005 | 1248 | 0.270 |
Why?
|
| Rats | 33 | 2021 | 23717 | 0.270 |
Why?
|
| Skin | 8 | 2021 | 4473 | 0.270 |
Why?
|
| Dermis | 2 | 2005 | 202 | 0.270 |
Why?
|
| Alkaline Phosphatase | 7 | 2012 | 860 | 0.250 |
Why?
|
| Nicotinic Agonists | 1 | 2007 | 265 | 0.250 |
Why?
|
| Blood Substitutes | 1 | 2005 | 57 | 0.250 |
Why?
|
| Humans | 97 | 2022 | 760617 | 0.250 |
Why?
|
| Calcium, Dietary | 1 | 2008 | 529 | 0.250 |
Why?
|
| Interleukin-6 | 6 | 2018 | 3206 | 0.250 |
Why?
|
| Hematopoiesis | 3 | 2012 | 2049 | 0.240 |
Why?
|
| Regeneration | 4 | 2003 | 1505 | 0.240 |
Why?
|
| Osteoprotegerin | 3 | 2014 | 176 | 0.240 |
Why?
|
| Polymorphism, Genetic | 1 | 2015 | 4242 | 0.240 |
Why?
|
| Cranial Sutures | 2 | 2004 | 92 | 0.240 |
Why?
|
| Aggrecans | 4 | 2006 | 89 | 0.230 |
Why?
|
| Estrogen Receptor alpha | 3 | 2017 | 583 | 0.230 |
Why?
|
| Sterilization | 1 | 2005 | 132 | 0.230 |
Why?
|
| Skull | 8 | 2012 | 818 | 0.230 |
Why?
|
| Wounds and Injuries | 2 | 2014 | 2491 | 0.230 |
Why?
|
| Aged | 32 | 2020 | 169042 | 0.220 |
Why?
|
| Bioprosthesis | 2 | 2008 | 591 | 0.220 |
Why?
|
| Macrophage Colony-Stimulating Factor | 2 | 2014 | 186 | 0.220 |
Why?
|
| Female | 64 | 2020 | 392148 | 0.220 |
Why?
|
| Acid Phosphatase | 9 | 2007 | 139 | 0.220 |
Why?
|
| Hindlimb | 2 | 2010 | 513 | 0.210 |
Why?
|
| Craniosynostoses | 3 | 2004 | 412 | 0.210 |
Why?
|
| Nicotine | 1 | 2007 | 679 | 0.210 |
Why?
|
| Male | 65 | 2021 | 360358 | 0.210 |
Why?
|
| Internship and Residency | 1 | 2022 | 5878 | 0.200 |
Why?
|
| Craniotomy | 4 | 2012 | 741 | 0.200 |
Why?
|
| Calcitriol | 3 | 2012 | 296 | 0.190 |
Why?
|
| Osteitis | 1 | 2001 | 33 | 0.190 |
Why?
|
| Swine, Miniature | 7 | 2010 | 961 | 0.190 |
Why?
|
| Dihydrotestosterone | 1 | 2001 | 195 | 0.190 |
Why?
|
| Trans-Activators | 3 | 2005 | 2852 | 0.180 |
Why?
|
| Dental Restoration Failure | 1 | 2001 | 155 | 0.180 |
Why?
|
| Proteoglycans | 5 | 2005 | 803 | 0.180 |
Why?
|
| Fractures, Ununited | 2 | 1999 | 175 | 0.180 |
Why?
|
| Middle Aged | 35 | 2020 | 220584 | 0.180 |
Why?
|
| Stem Cells | 4 | 2011 | 3516 | 0.170 |
Why?
|
| Hip Joint | 1 | 2007 | 1014 | 0.170 |
Why?
|
| Polyglycolic Acid | 1 | 2001 | 406 | 0.170 |
Why?
|
| Gene Expression Profiling | 4 | 2011 | 9417 | 0.170 |
Why?
|
| Bone Screws | 1 | 2003 | 530 | 0.170 |
Why?
|
| Lower Extremity | 2 | 2008 | 1200 | 0.170 |
Why?
|
| Bone Cysts | 1 | 1999 | 48 | 0.160 |
Why?
|
| Genotype | 1 | 2014 | 12978 | 0.160 |
Why?
|
| Estrogen Replacement Therapy | 4 | 2001 | 1208 | 0.160 |
Why?
|
| Mandibular Advancement | 3 | 2004 | 64 | 0.160 |
Why?
|
| Joints | 1 | 2001 | 322 | 0.160 |
Why?
|
| Fibrous Dysplasia of Bone | 1 | 1999 | 53 | 0.160 |
Why?
|
| Hemangioma | 5 | 1986 | 727 | 0.160 |
Why?
|
| Ossification, Heterotopic | 1 | 2001 | 235 | 0.160 |
Why?
|
| Fractures, Bone | 3 | 2002 | 2044 | 0.160 |
Why?
|
| Oligonucleotide Array Sequence Analysis | 2 | 2005 | 3777 | 0.150 |
Why?
|
| Mice, SCID | 3 | 2014 | 2625 | 0.150 |
Why?
|
| Blotting, Western | 3 | 2011 | 5034 | 0.150 |
Why?
|
| Receptors, TNF-Related Apoptosis-Inducing Ligand | 1 | 2017 | 58 | 0.150 |
Why?
|
| Methylmethacrylates | 2 | 1988 | 67 | 0.140 |
Why?
|
| Hyaluronic Acid | 1 | 2001 | 483 | 0.140 |
Why?
|
| Chick Embryo | 4 | 2004 | 982 | 0.140 |
Why?
|
| Obesity | 1 | 2019 | 12933 | 0.140 |
Why?
|
| Flavonols | 1 | 2017 | 85 | 0.140 |
Why?
|
| Connective Tissue Cells | 1 | 1996 | 49 | 0.140 |
Why?
|
| Bone Remodeling | 3 | 2009 | 581 | 0.140 |
Why?
|
| Parietal Bone | 2 | 2011 | 49 | 0.140 |
Why?
|
| Gene Expression Regulation, Enzymologic | 2 | 2011 | 1169 | 0.140 |
Why?
|
| Lactic Acid | 1 | 2001 | 1139 | 0.130 |
Why?
|
| Activin Receptors, Type II | 1 | 2017 | 123 | 0.130 |
Why?
|
| Mice | 20 | 2021 | 81368 | 0.130 |
Why?
|
| Oligopeptides | 1 | 2001 | 1185 | 0.130 |
Why?
|
| Porosity | 2 | 2008 | 348 | 0.130 |
Why?
|
| Fingers | 2 | 1992 | 506 | 0.130 |
Why?
|
| Adult | 28 | 2022 | 220969 | 0.130 |
Why?
|
| Up-Regulation | 4 | 2008 | 4117 | 0.130 |
Why?
|
| Arthroplasty, Replacement, Hip | 2 | 2003 | 1413 | 0.130 |
Why?
|
| Receptors, Cytoplasmic and Nuclear | 1 | 2000 | 858 | 0.120 |
Why?
|
| Connective Tissue | 4 | 2010 | 419 | 0.120 |
Why?
|
| Calcitonin | 2 | 1988 | 329 | 0.120 |
Why?
|
| Tissue Banks | 1 | 1996 | 184 | 0.120 |
Why?
|
| Aged, 80 and over | 13 | 2020 | 58894 | 0.120 |
Why?
|
| beta Catenin | 3 | 2011 | 1039 | 0.120 |
Why?
|
| Receptor Activator of Nuclear Factor-kappa B | 1 | 2014 | 77 | 0.120 |
Why?
|
| Receptor, Macrophage Colony-Stimulating Factor | 1 | 2014 | 94 | 0.120 |
Why?
|
| Polymers | 1 | 2001 | 1614 | 0.120 |
Why?
|
| MAP Kinase Signaling System | 2 | 2016 | 1483 | 0.120 |
Why?
|
| Osteosarcoma | 2 | 1999 | 896 | 0.120 |
Why?
|
| Sex Factors | 3 | 2015 | 10548 | 0.110 |
Why?
|
| Minerals | 4 | 1987 | 283 | 0.110 |
Why?
|
| Puberty | 1 | 2017 | 501 | 0.110 |
Why?
|
| Fibroblast Growth Factors | 1 | 2020 | 865 | 0.110 |
Why?
|
| Chondroitin Sulfates | 4 | 2005 | 174 | 0.110 |
Why?
|
| Maxilla | 2 | 2010 | 494 | 0.110 |
Why?
|
| Hydroxyapatites | 2 | 1990 | 73 | 0.110 |
Why?
|
| Receptor, IGF Type 1 | 1 | 2016 | 380 | 0.110 |
Why?
|
| Age Factors | 5 | 2017 | 18381 | 0.110 |
Why?
|
| RNA, Messenger | 8 | 2006 | 12758 | 0.110 |
Why?
|
| Granulocyte-Macrophage Colony-Stimulating Factor | 2 | 1994 | 888 | 0.110 |
Why?
|
| Neovascularization, Physiologic | 2 | 2010 | 1349 | 0.110 |
Why?
|
| Receptors, Fc | 1 | 2017 | 534 | 0.110 |
Why?
|
| Osteotomy | 5 | 2007 | 836 | 0.110 |
Why?
|
| Dental Implants | 1 | 2001 | 795 | 0.110 |
Why?
|
| Oxygen | 1 | 2005 | 4226 | 0.110 |
Why?
|
| Recombinant Proteins | 2 | 2015 | 6520 | 0.110 |
Why?
|
| Metacarpus | 1 | 1992 | 36 | 0.100 |
Why?
|
| Blotting, Northern | 3 | 2005 | 1545 | 0.100 |
Why?
|
| Probability | 2 | 2011 | 2475 | 0.100 |
Why?
|
| Simian Acquired Immunodeficiency Syndrome | 1 | 2017 | 541 | 0.100 |
Why?
|
| Radiation-Protective Agents | 2 | 2010 | 88 | 0.100 |
Why?
|
| Rats, Inbred Strains | 5 | 2001 | 2088 | 0.100 |
Why?
|
| Insulin-Like Growth Factor Binding Protein 3 | 2 | 2009 | 416 | 0.100 |
Why?
|
| Perfusion | 4 | 2001 | 1373 | 0.100 |
Why?
|
| Glycoproteins | 1 | 2000 | 2200 | 0.100 |
Why?
|
| RNA-Binding Proteins | 1 | 2001 | 1890 | 0.100 |
Why?
|
| Cell Proliferation | 4 | 2017 | 10432 | 0.100 |
Why?
|
| Naphthols | 1 | 2011 | 46 | 0.100 |
Why?
|
| Tyrphostins | 1 | 2011 | 63 | 0.100 |
Why?
|
| Calcification, Physiologic | 3 | 2012 | 170 | 0.100 |
Why?
|
| Simian immunodeficiency virus | 1 | 2017 | 810 | 0.100 |
Why?
|
| Cephalometry | 3 | 2010 | 382 | 0.090 |
Why?
|
| Cell Separation | 2 | 2017 | 1718 | 0.090 |
Why?
|
| Cytokines | 4 | 2011 | 7373 | 0.090 |
Why?
|
| Proto-Oncogene Proteins | 1 | 2003 | 4512 | 0.090 |
Why?
|
| Osteopetrosis | 2 | 1989 | 43 | 0.090 |
Why?
|
| Models, Animal | 3 | 2010 | 2109 | 0.090 |
Why?
|
| Maleimides | 1 | 2011 | 112 | 0.090 |
Why?
|
| Safety | 1 | 2015 | 1149 | 0.090 |
Why?
|
| DNA-Binding Proteins | 2 | 2005 | 9586 | 0.090 |
Why?
|
| Calcium-Binding Proteins | 4 | 1997 | 1066 | 0.090 |
Why?
|
| Facial Bones | 2 | 2007 | 208 | 0.090 |
Why?
|
| Glycosaminoglycans | 2 | 2005 | 607 | 0.090 |
Why?
|
| Cyclic N-Oxides | 1 | 2010 | 72 | 0.090 |
Why?
|
| Frontal Bone | 1 | 2011 | 105 | 0.090 |
Why?
|
| Transplantation, Autologous | 4 | 2012 | 2112 | 0.090 |
Why?
|
| Swine | 7 | 2010 | 5907 | 0.090 |
Why?
|
| Hematopoietic Stem Cells | 5 | 2005 | 3394 | 0.090 |
Why?
|
| Microscopy, Electron | 7 | 1991 | 2561 | 0.090 |
Why?
|
| Electroporation | 1 | 2011 | 233 | 0.090 |
Why?
|
| Histocytochemistry | 5 | 2001 | 696 | 0.090 |
Why?
|
| Cell Division | 7 | 2001 | 4457 | 0.090 |
Why?
|
| Foot Joints | 1 | 2010 | 35 | 0.090 |
Why?
|
| bcl-2-Associated X Protein | 1 | 2011 | 282 | 0.090 |
Why?
|
| Ceramics | 1 | 1990 | 113 | 0.090 |
Why?
|
| Cell Survival | 5 | 2012 | 5780 | 0.080 |
Why?
|
| Interleukin-1beta | 1 | 2015 | 998 | 0.080 |
Why?
|
| HEK293 Cells | 1 | 2019 | 4269 | 0.080 |
Why?
|
| Disease Models, Animal | 7 | 2021 | 18221 | 0.080 |
Why?
|
| Isoquinolines | 1 | 2011 | 352 | 0.080 |
Why?
|
| Mice, Inbred NOD | 1 | 2014 | 1827 | 0.080 |
Why?
|
| Chondroitin | 1 | 2009 | 64 | 0.080 |
Why?
|
| Rats, Sprague-Dawley | 3 | 2021 | 8166 | 0.080 |
Why?
|
| Curriculum | 1 | 2022 | 3738 | 0.080 |
Why?
|
| Dehydroepiandrosterone Sulfate | 2 | 2000 | 241 | 0.080 |
Why?
|
| Tartrates | 4 | 1994 | 12 | 0.080 |
Why?
|
| Cyclic AMP-Dependent Protein Kinases | 1 | 2011 | 485 | 0.080 |
Why?
|
| Child | 14 | 2017 | 80079 | 0.080 |
Why?
|
| Mast Cells | 3 | 1986 | 1392 | 0.080 |
Why?
|
| Osteochondrodysplasias | 2 | 1994 | 182 | 0.080 |
Why?
|
| Arthrodesis | 1 | 2010 | 186 | 0.080 |
Why?
|
| Cytoskeletal Proteins | 2 | 2004 | 1336 | 0.080 |
Why?
|
| Lipoprotein Lipase | 2 | 2005 | 133 | 0.070 |
Why?
|
| Biological Assay | 2 | 2005 | 626 | 0.070 |
Why?
|
| Smad3 Protein | 2 | 2005 | 166 | 0.070 |
Why?
|
| Plasminogen Activator Inhibitor 1 | 1 | 2009 | 277 | 0.070 |
Why?
|
| Dental Arch | 1 | 2007 | 43 | 0.070 |
Why?
|
| Insulin-Like Growth Factor Binding Proteins | 1 | 2009 | 208 | 0.070 |
Why?
|
| Histone Deacetylases | 1 | 2012 | 719 | 0.070 |
Why?
|
| Carrier Proteins | 1 | 2001 | 4935 | 0.070 |
Why?
|
| Cholecalciferol | 2 | 2012 | 553 | 0.070 |
Why?
|
| Materials Testing | 2 | 2001 | 862 | 0.070 |
Why?
|
| Neoplasm Proteins | 1 | 1999 | 3607 | 0.070 |
Why?
|
| Time Factors | 10 | 2014 | 39913 | 0.070 |
Why?
|
| Histone Deacetylase Inhibitors | 1 | 2012 | 774 | 0.070 |
Why?
|
| Arginine Vasopressin | 1 | 2007 | 125 | 0.070 |
Why?
|
| Dexamethasone | 2 | 2011 | 1947 | 0.070 |
Why?
|
| Sialoglycoproteins | 2 | 1999 | 315 | 0.070 |
Why?
|
| Dental Stress Analysis | 2 | 2003 | 64 | 0.070 |
Why?
|
| Tissue and Organ Harvesting | 1 | 2010 | 373 | 0.070 |
Why?
|
| Mitogen-Activated Protein Kinases | 1 | 2011 | 1242 | 0.070 |
Why?
|
| Kinetics | 4 | 2002 | 6370 | 0.070 |
Why?
|
| Mice, Inbred C57BL | 8 | 2014 | 22115 | 0.070 |
Why?
|
| Osteopontin | 2 | 1999 | 301 | 0.070 |
Why?
|
| Diphosphonates | 1 | 2011 | 635 | 0.070 |
Why?
|
| Genetic Association Studies | 1 | 2015 | 2734 | 0.060 |
Why?
|
| Kidney | 3 | 2020 | 7045 | 0.060 |
Why?
|
| Rabbits | 6 | 2012 | 4770 | 0.060 |
Why?
|
| PPAR gamma | 2 | 2005 | 484 | 0.060 |
Why?
|
| Radiation Dosage | 1 | 2014 | 1956 | 0.060 |
Why?
|
| Sharks | 1 | 1985 | 21 | 0.060 |
Why?
|
| Bone Marrow | 3 | 2017 | 2909 | 0.060 |
Why?
|
| Ethylene Oxide | 1 | 2005 | 28 | 0.060 |
Why?
|
| Culture Media, Serum-Free | 1 | 2005 | 148 | 0.060 |
Why?
|
| Vitamin K | 1 | 1987 | 313 | 0.060 |
Why?
|
| Smad2 Protein | 1 | 2005 | 145 | 0.060 |
Why?
|
| Copper | 1 | 1987 | 367 | 0.060 |
Why?
|
| Facial Neoplasms | 1 | 1986 | 125 | 0.060 |
Why?
|
| Arthritis | 1 | 2010 | 680 | 0.060 |
Why?
|
| Manganese | 1 | 1987 | 393 | 0.060 |
Why?
|
| Bone Marrow Transplantation | 2 | 2009 | 2690 | 0.060 |
Why?
|
| Physical Endurance | 1 | 2007 | 366 | 0.060 |
Why?
|
| Oral Surgical Procedures, Preprosthetic | 1 | 1984 | 28 | 0.060 |
Why?
|
| Cell Adhesion | 3 | 2001 | 3088 | 0.060 |
Why?
|
| Alveolar Ridge Augmentation | 2 | 1984 | 208 | 0.060 |
Why?
|
| Hyponatremia | 1 | 2007 | 279 | 0.060 |
Why?
|
| Receptors, Cell Surface | 2 | 1997 | 2802 | 0.060 |
Why?
|
| Femoral Fractures | 1 | 2008 | 375 | 0.060 |
Why?
|
| Wnt2 Protein | 1 | 2003 | 28 | 0.060 |
Why?
|
| Immunohistochemistry | 6 | 2011 | 11069 | 0.060 |
Why?
|
| Delayed-Action Preparations | 1 | 2007 | 962 | 0.060 |
Why?
|
| Polyethylenes | 1 | 1986 | 290 | 0.060 |
Why?
|
| Bone Neoplasms | 1 | 1996 | 2527 | 0.060 |
Why?
|
| Base Sequence | 4 | 2005 | 12421 | 0.050 |
Why?
|
| Procollagen-Lysine, 2-Oxoglutarate 5-Dioxygenase | 1 | 2003 | 7 | 0.050 |
Why?
|
| Receptors, Collagen | 1 | 2003 | 25 | 0.050 |
Why?
|
| Women's Health | 1 | 2013 | 2065 | 0.050 |
Why?
|
| Polymerase Chain Reaction | 2 | 2011 | 6074 | 0.050 |
Why?
|
| Collagen Type XI | 1 | 2003 | 21 | 0.050 |
Why?
|
| Protamines | 1 | 1983 | 112 | 0.050 |
Why?
|
| Placebos | 1 | 2007 | 1667 | 0.050 |
Why?
|
| Transfection | 1 | 2011 | 5766 | 0.050 |
Why?
|
| Decorin | 1 | 2003 | 38 | 0.050 |
Why?
|
| Periodontal Diseases | 2 | 1984 | 451 | 0.050 |
Why?
|
| Radiography | 5 | 2010 | 6961 | 0.050 |
Why?
|
| NF-kappa B | 1 | 2011 | 2481 | 0.050 |
Why?
|
| Glutathione | 1 | 2005 | 582 | 0.050 |
Why?
|
| Transplantation, Homologous | 5 | 2005 | 4804 | 0.050 |
Why?
|
| Isoenzymes | 1 | 2007 | 1687 | 0.050 |
Why?
|
| Indoles | 1 | 2011 | 1830 | 0.050 |
Why?
|
| Superoxide Dismutase | 1 | 2005 | 593 | 0.050 |
Why?
|
| Protein-Lysine 6-Oxidase | 1 | 2003 | 55 | 0.050 |
Why?
|
| Biopsy | 2 | 2009 | 6762 | 0.050 |
Why?
|
| Cell Line | 4 | 2003 | 15576 | 0.050 |
Why?
|
| Collagen Type III | 1 | 2003 | 91 | 0.050 |
Why?
|
| Glucocorticoids | 1 | 1992 | 2160 | 0.050 |
Why?
|
| Hydrostatic Pressure | 1 | 2002 | 98 | 0.050 |
Why?
|
| Integrin alpha Chains | 1 | 2003 | 95 | 0.050 |
Why?
|
| Running | 1 | 2007 | 488 | 0.050 |
Why?
|
| Reproducibility of Results | 4 | 2010 | 20074 | 0.050 |
Why?
|
| Musculoskeletal Diseases | 1 | 2008 | 597 | 0.050 |
Why?
|
| Jaw Diseases | 1 | 1982 | 92 | 0.050 |
Why?
|
| Hypercalcemia | 1 | 1985 | 423 | 0.050 |
Why?
|
| Orthopedics | 1 | 2011 | 898 | 0.050 |
Why?
|
| Osteomalacia | 1 | 2002 | 60 | 0.050 |
Why?
|
| Bone Morphogenetic Protein 4 | 1 | 2002 | 163 | 0.050 |
Why?
|
| Sulfates | 1 | 2002 | 379 | 0.050 |
Why?
|
| Review Literature as Topic | 1 | 2004 | 347 | 0.050 |
Why?
|
| DNA, Complementary | 1 | 2005 | 1989 | 0.050 |
Why?
|
| Sulfonamides | 1 | 2011 | 1977 | 0.050 |
Why?
|
| RNA | 2 | 2005 | 2713 | 0.050 |
Why?
|
| Reference Values | 2 | 2010 | 4919 | 0.050 |
Why?
|
| Masseter Muscle | 1 | 2001 | 38 | 0.050 |
Why?
|
| Bone Development | 2 | 1998 | 470 | 0.050 |
Why?
|
| Craniofacial Dysostosis | 1 | 1981 | 74 | 0.050 |
Why?
|
| Hypoxia-Inducible Factor 1, alpha Subunit | 1 | 2005 | 619 | 0.050 |
Why?
|
| Stress, Mechanical | 2 | 2003 | 1674 | 0.050 |
Why?
|
| Calcium | 6 | 1999 | 5717 | 0.050 |
Why?
|
| Enzyme Inhibitors | 1 | 2011 | 3705 | 0.050 |
Why?
|
| Oxidative Stress | 1 | 2012 | 3113 | 0.050 |
Why?
|
| Polymethyl Methacrylate | 1 | 2001 | 132 | 0.040 |
Why?
|
| Mandibular Diseases | 1 | 1981 | 119 | 0.040 |
Why?
|
| Titanium | 1 | 2003 | 485 | 0.040 |
Why?
|
| Warfarin | 3 | 1991 | 1477 | 0.040 |
Why?
|
| Knee | 1 | 2002 | 279 | 0.040 |
Why?
|
| Povidone | 1 | 1980 | 30 | 0.040 |
Why?
|
| Calcium Phosphates | 1 | 2001 | 171 | 0.040 |
Why?
|
| Adolescent | 11 | 2013 | 88234 | 0.040 |
Why?
|
| Nasal Bone | 1 | 1980 | 57 | 0.040 |
Why?
|
| Tumor Cells, Cultured | 2 | 1999 | 6126 | 0.040 |
Why?
|
| Polyethylene | 1 | 2001 | 185 | 0.040 |
Why?
|
| Core Binding Factors | 1 | 1999 | 29 | 0.040 |
Why?
|
| Risk Factors | 4 | 2011 | 74115 | 0.040 |
Why?
|
| Povidone-Iodine | 1 | 1980 | 55 | 0.040 |
Why?
|
| Accidental Falls | 1 | 2008 | 1065 | 0.040 |
Why?
|
| Case-Control Studies | 2 | 2011 | 22148 | 0.040 |
Why?
|
| Bone Morphogenetic Protein 7 | 1 | 2020 | 110 | 0.040 |
Why?
|
| Nutritional Status | 1 | 2008 | 1596 | 0.040 |
Why?
|
| Bone Cements | 1 | 2001 | 325 | 0.040 |
Why?
|
| Phosphatidylinositol 3-Kinases | 2 | 2021 | 2864 | 0.040 |
Why?
|
| Cell Movement | 2 | 2005 | 5200 | 0.040 |
Why?
|
| Core Binding Factor Alpha 1 Subunit | 1 | 1999 | 158 | 0.040 |
Why?
|
| Adrenal Glands | 1 | 2001 | 552 | 0.040 |
Why?
|
| Absorbable Implants | 1 | 2001 | 338 | 0.040 |
Why?
|
| Microscopy, Electron, Scanning | 1 | 2001 | 944 | 0.040 |
Why?
|
| Severity of Illness Index | 2 | 2010 | 15828 | 0.040 |
Why?
|
| Epigenesis, Genetic | 1 | 2012 | 3794 | 0.040 |
Why?
|
| Mouth Mucosa | 1 | 2001 | 432 | 0.040 |
Why?
|
| Receptor, Fibroblast Growth Factor, Type 1 | 1 | 2020 | 257 | 0.040 |
Why?
|
| Bioreactors | 1 | 2000 | 246 | 0.040 |
Why?
|
| Sensitivity and Specificity | 2 | 2007 | 14648 | 0.040 |
Why?
|
| Cell Communication | 1 | 1986 | 1654 | 0.040 |
Why?
|
| Lymphangioma | 3 | 1983 | 61 | 0.040 |
Why?
|
| Porifera | 1 | 1998 | 32 | 0.040 |
Why?
|
| Decalcification Technique | 2 | 1992 | 6 | 0.040 |
Why?
|
| Integrin alpha2 | 1 | 1998 | 39 | 0.040 |
Why?
|
| Interleukin-11 | 1 | 1998 | 58 | 0.040 |
Why?
|
| Cell Count | 3 | 1997 | 1835 | 0.040 |
Why?
|
| Prevalence | 2 | 2008 | 15689 | 0.040 |
Why?
|
| Surface Properties | 1 | 2001 | 1161 | 0.040 |
Why?
|
| Phenylmethylsulfonyl Fluoride | 1 | 1997 | 6 | 0.040 |
Why?
|
| Temporomandibular Joint Disorders | 1 | 2001 | 222 | 0.040 |
Why?
|
| Cocaine | 1 | 2003 | 958 | 0.040 |
Why?
|
| Insulin-Like Growth Factor Binding Protein 4 | 1 | 1997 | 24 | 0.040 |
Why?
|
| Insulin-Like Growth Factor Binding Protein 5 | 1 | 1997 | 28 | 0.040 |
Why?
|
| Veins | 1 | 1982 | 767 | 0.040 |
Why?
|
| Cell Adhesion Molecules | 1 | 2004 | 1602 | 0.040 |
Why?
|
| Keratinocytes | 1 | 2001 | 790 | 0.040 |
Why?
|
| Antioxidants | 1 | 2005 | 1668 | 0.040 |
Why?
|
| Receptors, Tumor Necrosis Factor | 1 | 2000 | 581 | 0.040 |
Why?
|
| Dental Implantation, Endosseous | 1 | 2001 | 530 | 0.040 |
Why?
|
| Recovery of Function | 2 | 2008 | 2978 | 0.040 |
Why?
|
| HT29 Cells | 1 | 2017 | 192 | 0.040 |
Why?
|
| Synovitis, Pigmented Villonodular | 1 | 1997 | 32 | 0.040 |
Why?
|
| Tumor Suppressor Protein p53 | 1 | 2008 | 2917 | 0.040 |
Why?
|
| Ovary | 1 | 2001 | 959 | 0.040 |
Why?
|
| Phenotype | 4 | 2005 | 16571 | 0.040 |
Why?
|
| Transferrin | 1 | 1998 | 283 | 0.040 |
Why?
|
| Giant Cell Tumors | 1 | 1997 | 89 | 0.030 |
Why?
|
| Evaluation Studies as Topic | 3 | 1984 | 1623 | 0.030 |
Why?
|
| Arteries | 1 | 1982 | 1122 | 0.030 |
Why?
|
| Body Composition | 2 | 2012 | 2426 | 0.030 |
Why?
|
| Osteonecrosis | 1 | 1998 | 229 | 0.030 |
Why?
|
| Dose-Response Relationship, Drug | 1 | 2009 | 10754 | 0.030 |
Why?
|
| Intercellular Signaling Peptides and Proteins | 1 | 2004 | 1650 | 0.030 |
Why?
|
| Blood Vessels | 1 | 1982 | 1113 | 0.030 |
Why?
|
| Risk Assessment | 2 | 2011 | 23972 | 0.030 |
Why?
|
| Follow-Up Studies | 5 | 2003 | 39063 | 0.030 |
Why?
|
| Electrophoresis, Agar Gel | 1 | 1996 | 206 | 0.030 |
Why?
|
| Heparin | 1 | 1983 | 1632 | 0.030 |
Why?
|
| Surgery, Plastic | 4 | 1985 | 641 | 0.030 |
Why?
|
| Alveolar Process | 2 | 1990 | 294 | 0.030 |
Why?
|
| Hydrocortisone | 3 | 2007 | 1819 | 0.030 |
Why?
|
| Collagen Type I | 1 | 1999 | 616 | 0.030 |
Why?
|
| MicroRNAs | 1 | 2011 | 3805 | 0.030 |
Why?
|
| DNA Primers | 1 | 2000 | 2817 | 0.030 |
Why?
|
| Down-Regulation | 1 | 2003 | 2915 | 0.030 |
Why?
|
| Culture Techniques | 1 | 1996 | 531 | 0.030 |
Why?
|
| Methods | 3 | 1998 | 1065 | 0.030 |
Why?
|
| Hemostatics | 1 | 1998 | 240 | 0.030 |
Why?
|
| Selenium | 1 | 1998 | 417 | 0.030 |
Why?
|
| Dietary Supplements | 1 | 2008 | 3411 | 0.030 |
Why?
|
| Tissue Donors | 2 | 2017 | 2331 | 0.030 |
Why?
|
| Regional Blood Flow | 1 | 1998 | 1496 | 0.030 |
Why?
|
| Cell Size | 1 | 1996 | 624 | 0.030 |
Why?
|
| Linear Models | 1 | 2004 | 5866 | 0.030 |
Why?
|
| Mitogen-Activated Protein Kinase 1 | 1 | 2016 | 476 | 0.030 |
Why?
|
| Receptors, Calcitonin | 2 | 1997 | 34 | 0.030 |
Why?
|
| Protease Inhibitors | 1 | 1997 | 753 | 0.030 |
Why?
|
| Prosthesis Design | 1 | 2001 | 2114 | 0.030 |
Why?
|
| Infant | 8 | 2004 | 36152 | 0.030 |
Why?
|
| Bony Callus | 2 | 2003 | 41 | 0.030 |
Why?
|
| Radioimmunoassay | 2 | 2007 | 861 | 0.030 |
Why?
|
| Genetic Predisposition to Disease | 1 | 2015 | 17878 | 0.030 |
Why?
|
| DNA | 3 | 2001 | 7196 | 0.030 |
Why?
|
| Embryonic and Fetal Development | 1 | 1994 | 420 | 0.030 |
Why?
|
| Child, Preschool | 8 | 2004 | 42188 | 0.030 |
Why?
|
| Mice, Inbred BALB C | 3 | 1997 | 6188 | 0.030 |
Why?
|
| Culture Media, Conditioned | 1 | 1994 | 522 | 0.030 |
Why?
|
| p38 Mitogen-Activated Protein Kinases | 1 | 2016 | 682 | 0.030 |
Why?
|
| Tendons | 1 | 1997 | 558 | 0.030 |
Why?
|
| Steroids | 1 | 1998 | 929 | 0.030 |
Why?
|
| Skin Neoplasms | 2 | 1982 | 5812 | 0.030 |
Why?
|
| Radiation Chimera | 1 | 1992 | 215 | 0.030 |
Why?
|
| Neoplasm Transplantation | 1 | 1996 | 2010 | 0.030 |
Why?
|
| Cell Cycle Proteins | 1 | 2004 | 3447 | 0.030 |
Why?
|
| Polyethylene Glycols | 1 | 1998 | 1182 | 0.030 |
Why?
|
| Transcription Factors | 2 | 2004 | 12116 | 0.020 |
Why?
|
| Apoptosis | 1 | 2008 | 9476 | 0.020 |
Why?
|
| Apatites | 1 | 1991 | 19 | 0.020 |
Why?
|
| Glomerular Filtration Rate | 1 | 2020 | 2178 | 0.020 |
Why?
|
| Haversian System | 1 | 2010 | 9 | 0.020 |
Why?
|
| Spectrophotometry, Infrared | 1 | 1991 | 117 | 0.020 |
Why?
|
| Hematoxylin | 1 | 2010 | 60 | 0.020 |
Why?
|
| Statistics, Nonparametric | 2 | 2011 | 2849 | 0.020 |
Why?
|
| Eosine Yellowish-(YS) | 1 | 2010 | 69 | 0.020 |
Why?
|
| Freeze Drying | 2 | 1981 | 101 | 0.020 |
Why?
|
| Fluorescent Antibody Technique | 2 | 1994 | 2467 | 0.020 |
Why?
|
| Fibrin Tissue Adhesive | 1 | 2011 | 86 | 0.020 |
Why?
|
| Macaca mulatta | 1 | 2017 | 2328 | 0.020 |
Why?
|
| Osteotomy, Le Fort | 1 | 2010 | 93 | 0.020 |
Why?
|
| Nitric Oxide Synthase Type II | 1 | 2011 | 517 | 0.020 |
Why?
|
| Periosteum | 1 | 2010 | 136 | 0.020 |
Why?
|
| Genes | 1 | 1994 | 1823 | 0.020 |
Why?
|
| Ligands | 1 | 2017 | 3268 | 0.020 |
Why?
|
| Radiation, Ionizing | 1 | 2010 | 251 | 0.020 |
Why?
|
| Rats, Mutant Strains | 1 | 1989 | 60 | 0.020 |
Why?
|
| Durapatite | 1 | 1990 | 163 | 0.020 |
Why?
|
| Body Mass Index | 1 | 2007 | 12943 | 0.020 |
Why?
|
| Comorbidity | 1 | 2003 | 10505 | 0.020 |
Why?
|
| Spin Labels | 1 | 2010 | 337 | 0.020 |
Why?
|
| Dose-Response Relationship, Radiation | 1 | 2010 | 880 | 0.020 |
Why?
|
| X-Ray Microtomography | 1 | 2011 | 455 | 0.020 |
Why?
|
| Young Adult | 2 | 2017 | 59179 | 0.020 |
Why?
|
| Retrospective Studies | 3 | 2008 | 80566 | 0.020 |
Why?
|
| Hospitalization | 1 | 2008 | 10704 | 0.020 |
Why?
|
| Coloring Agents | 1 | 2010 | 562 | 0.020 |
Why?
|
| Ribs | 2 | 1994 | 252 | 0.020 |
Why?
|
| Antigens, CD | 1 | 1998 | 3998 | 0.020 |
Why?
|
| Blood Urea Nitrogen | 1 | 2007 | 185 | 0.020 |
Why?
|
| Transcription, Genetic | 1 | 2001 | 7583 | 0.020 |
Why?
|
| Inappropriate ADH Syndrome | 1 | 2007 | 61 | 0.020 |
Why?
|
| Peptides | 1 | 1999 | 4354 | 0.020 |
Why?
|
| Recurrence | 1 | 1999 | 8426 | 0.020 |
Why?
|
| Menopause | 1 | 1995 | 1645 | 0.020 |
Why?
|
| Particle Size | 1 | 2010 | 1648 | 0.020 |
Why?
|
| Body Weight | 1 | 2017 | 4614 | 0.020 |
Why?
|
| Random Allocation | 1 | 2010 | 2392 | 0.020 |
Why?
|
| Testosterone | 1 | 2017 | 2472 | 0.020 |
Why?
|
| Amifostine | 1 | 2005 | 40 | 0.020 |
Why?
|
| Trace Elements | 1 | 1987 | 195 | 0.020 |
Why?
|
| Mice, Mutant Strains | 1 | 1989 | 1748 | 0.020 |
Why?
|
| Structure-Activity Relationship | 1 | 2011 | 3074 | 0.020 |
Why?
|
| Incidence | 1 | 2003 | 21337 | 0.020 |
Why?
|
| Creatine Kinase | 1 | 2007 | 685 | 0.020 |
Why?
|
| History, 17th Century | 1 | 1985 | 108 | 0.020 |
Why?
|
| Hand Strength | 1 | 2008 | 456 | 0.020 |
Why?
|
| Prolactin | 1 | 2007 | 625 | 0.020 |
Why?
|
| Cell Nucleus | 2 | 2001 | 2894 | 0.020 |
Why?
|
| Treatment Outcome | 2 | 2003 | 64568 | 0.020 |
Why?
|
| History, 18th Century | 1 | 1985 | 206 | 0.010 |
Why?
|
| Humerus | 1 | 1986 | 272 | 0.010 |
Why?
|
| Transplantation, Isogeneic | 2 | 1981 | 248 | 0.010 |
Why?
|
| Mutation | 1 | 1989 | 30016 | 0.010 |
Why?
|
| Transplantation, Heterologous | 2 | 1984 | 2382 | 0.010 |
Why?
|
| Alveoloplasty | 1 | 1983 | 22 | 0.010 |
Why?
|
| England | 1 | 1985 | 526 | 0.010 |
Why?
|
| Neovascularization, Pathologic | 1 | 1994 | 2644 | 0.010 |
Why?
|
| Pliability | 1 | 2003 | 59 | 0.010 |
Why?
|
| Insulin | 1 | 1998 | 6593 | 0.010 |
Why?
|
| Infant, Newborn | 2 | 2003 | 26180 | 0.010 |
Why?
|
| Endothelium | 1 | 1986 | 764 | 0.010 |
Why?
|
| Polyhydroxyethyl Methacrylate | 1 | 1983 | 30 | 0.010 |
Why?
|
| Brain Edema | 1 | 2007 | 604 | 0.010 |
Why?
|
| Fluorescent Dyes | 1 | 2010 | 1901 | 0.010 |
Why?
|
| History, 19th Century | 1 | 1985 | 718 | 0.010 |
Why?
|
| Equipment Design | 1 | 2010 | 3501 | 0.010 |
Why?
|
| Methylene Chloride | 1 | 1982 | 11 | 0.010 |
Why?
|
| Clodronic Acid | 1 | 1982 | 59 | 0.010 |
Why?
|
| Langerhans Cells | 1 | 1982 | 170 | 0.010 |
Why?
|
| Glutaral | 1 | 2001 | 76 | 0.010 |
Why?
|
| Chromatography, Agarose | 1 | 1981 | 29 | 0.010 |
Why?
|
| Hypertelorism | 1 | 1981 | 29 | 0.010 |
Why?
|
| Fishes | 1 | 1985 | 602 | 0.010 |
Why?
|
| Ear Cartilage | 1 | 1981 | 62 | 0.010 |
Why?
|
| Microarray Analysis | 1 | 2004 | 748 | 0.010 |
Why?
|
| Phosphates | 1 | 1985 | 769 | 0.010 |
Why?
|
| Isoxsuprine | 1 | 1980 | 2 | 0.010 |
Why?
|
| Chromatography, Ion Exchange | 1 | 1981 | 297 | 0.010 |
Why?
|
| Adrenocorticotropic Hormone | 1 | 2003 | 618 | 0.010 |
Why?
|
| Oxidation-Reduction | 2 | 2005 | 2231 | 0.010 |
Why?
|
| Cohort Studies | 1 | 2003 | 41457 | 0.010 |
Why?
|
| Injections, Intravenous | 1 | 2003 | 1376 | 0.010 |
Why?
|
| Arteriovenous Malformations | 1 | 1983 | 396 | 0.010 |
Why?
|
| Chemical Phenomena | 2 | 1998 | 506 | 0.010 |
Why?
|
| Drug Implants | 1 | 1981 | 230 | 0.010 |
Why?
|
| Proliferating Cell Nuclear Antigen | 1 | 2001 | 283 | 0.010 |
Why?
|
| Internal Fixators | 1 | 2001 | 183 | 0.010 |
Why?
|
| Femur | 1 | 1986 | 1307 | 0.010 |
Why?
|
| Mice, Knockout | 2 | 2005 | 14389 | 0.010 |
Why?
|
| Parathyroid Glands | 1 | 1982 | 518 | 0.010 |
Why?
|
| Dogs | 1 | 1984 | 3838 | 0.010 |
Why?
|
| Adipose Tissue | 1 | 2011 | 3309 | 0.010 |
Why?
|
| Computational Biology | 1 | 2011 | 3509 | 0.010 |
Why?
|
| Patella | 1 | 1981 | 315 | 0.010 |
Why?
|
| Guinea Pigs | 1 | 1981 | 1310 | 0.010 |
Why?
|
| Menstrual Cycle | 1 | 2003 | 539 | 0.010 |
Why?
|
| Macrophages | 2 | 1986 | 5758 | 0.010 |
Why?
|
| Tensile Strength | 1 | 1980 | 330 | 0.010 |
Why?
|
| Proteins | 1 | 1994 | 6030 | 0.010 |
Why?
|
| Macromolecular Substances | 1 | 1981 | 1433 | 0.010 |
Why?
|
| Face | 1 | 1984 | 1026 | 0.010 |
Why?
|
| Cross-Linking Reagents | 1 | 2001 | 685 | 0.010 |
Why?
|
| Chemistry, Physical | 1 | 1998 | 154 | 0.010 |
Why?
|
| Europe | 1 | 1985 | 3413 | 0.010 |
Why?
|
| Wound Infection | 1 | 1980 | 244 | 0.010 |
Why?
|
| Vitronectin | 1 | 1997 | 40 | 0.010 |
Why?
|
| Immune Sera | 1 | 1997 | 605 | 0.010 |
Why?
|
| Viscosity | 1 | 1998 | 336 | 0.010 |
Why?
|
| Abnormalities, Multiple | 1 | 1984 | 1422 | 0.010 |
Why?
|
| History, 20th Century | 1 | 1985 | 2764 | 0.010 |
Why?
|
| Sequence Homology, Nucleic Acid | 1 | 1997 | 1058 | 0.010 |
Why?
|
| Congenital Abnormalities | 1 | 1981 | 709 | 0.010 |
Why?
|
| Premenopause | 1 | 2000 | 1038 | 0.010 |
Why?
|
| DNA Replication | 1 | 1983 | 1414 | 0.010 |
Why?
|
| Antibody Specificity | 1 | 1997 | 1058 | 0.010 |
Why?
|
| Cleft Palate | 1 | 1981 | 589 | 0.010 |
Why?
|
| HLA-DR Antigens | 1 | 1997 | 602 | 0.010 |
Why?
|
| Spinal Fusion | 1 | 1984 | 1275 | 0.010 |
Why?
|
| Sheep | 1 | 1998 | 1436 | 0.010 |
Why?
|
| Angiography | 1 | 1980 | 1596 | 0.010 |
Why?
|
| Terminology as Topic | 1 | 1982 | 1528 | 0.010 |
Why?
|
| Cycloheximide | 1 | 1994 | 343 | 0.010 |
Why?
|
| Antigens, Viral, Tumor | 1 | 1994 | 153 | 0.010 |
Why?
|
| Simian virus 40 | 1 | 1994 | 291 | 0.010 |
Why?
|
| Cicatrix | 1 | 1980 | 785 | 0.010 |
Why?
|
| In Situ Hybridization | 1 | 1997 | 1900 | 0.010 |
Why?
|
| Genes, Lethal | 1 | 1994 | 223 | 0.010 |
Why?
|
| Arteriosclerosis | 1 | 1998 | 1056 | 0.010 |
Why?
|
| Blotting, Southern | 1 | 1994 | 777 | 0.010 |
Why?
|
| Cell Transformation, Viral | 1 | 1994 | 526 | 0.010 |
Why?
|
| Graft Survival | 2 | 1981 | 3820 | 0.010 |
Why?
|
| Molecular Sequence Data | 2 | 1997 | 17629 | 0.010 |
Why?
|
| Monocytes | 1 | 1982 | 2565 | 0.010 |
Why?
|
| Cell Membrane | 1 | 1982 | 3680 | 0.010 |
Why?
|
| Parathyroid Hormone-Related Protein | 1 | 1994 | 327 | 0.010 |
Why?
|
| Oxytetracycline | 1 | 1991 | 11 | 0.010 |
Why?
|
| Surgical Flaps | 1 | 1980 | 1670 | 0.010 |
Why?
|
| Hand | 1 | 1997 | 902 | 0.010 |
Why?
|
| Mutagenesis, Site-Directed | 1 | 1994 | 1692 | 0.010 |
Why?
|
| Epithelial Cells | 1 | 1982 | 3672 | 0.010 |
Why?
|
| Androgens | 1 | 1998 | 1285 | 0.010 |
Why?
|
| Ultrasonography | 1 | 2003 | 5964 | 0.010 |
Why?
|
| Diet | 1 | 1987 | 8048 | 0.010 |
Why?
|
| Hematopoietic Stem Cell Transplantation | 1 | 1987 | 5672 | 0.010 |
Why?
|
| Knee Joint | 1 | 1997 | 1676 | 0.000 |
Why?
|
| Cloning, Molecular | 1 | 1994 | 4172 | 0.000 |
Why?
|
| Glycerophosphates | 1 | 1987 | 47 | 0.000 |
Why?
|
| Whole-Body Irradiation | 1 | 1987 | 432 | 0.000 |
Why?
|
| Gene Deletion | 1 | 1994 | 2661 | 0.000 |
Why?
|
| Phosphorus | 1 | 1987 | 335 | 0.000 |
Why?
|
| Recombinant Fusion Proteins | 1 | 1994 | 3730 | 0.000 |
Why?
|
| Protein Binding | 1 | 1974 | 9345 | 0.000 |
Why?
|
| Microradiography | 1 | 1980 | 13 | 0.000 |
Why?
|
| Facial Injuries | 1 | 1981 | 190 | 0.000 |
Why?
|
| Physical Examination | 1 | 1983 | 1254 | 0.000 |
Why?
|
| Necrosis | 1 | 1980 | 1610 | 0.000 |
Why?
|
| Hematoma | 1 | 1980 | 762 | 0.000 |
Why?
|
| Dihydroxycholecalciferols | 1 | 1974 | 17 | 0.000 |
Why?
|
| Hydroxycholecalciferols | 1 | 1974 | 44 | 0.000 |
Why?
|
| Chemistry | 1 | 1974 | 346 | 0.000 |
Why?
|
| Tritium | 1 | 1974 | 706 | 0.000 |
Why?
|
| Rickets | 1 | 1974 | 70 | 0.000 |
Why?
|
| Chromatography, Gel | 1 | 1974 | 645 | 0.000 |
Why?
|
| Ergocalciferols | 1 | 1974 | 110 | 0.000 |
Why?
|
| Carbon Radioisotopes | 1 | 1974 | 561 | 0.000 |
Why?
|
| Solubility | 1 | 1974 | 1089 | 0.000 |
Why?
|
| Chickens | 1 | 1974 | 858 | 0.000 |
Why?
|
| Electrophoresis, Polyacrylamide Gel | 1 | 1974 | 1738 | 0.000 |
Why?
|
| Biological Transport | 1 | 1974 | 2089 | 0.000 |
Why?
|
| Blood Proteins | 1 | 1974 | 1172 | 0.000 |
Why?
|